-
Price Momentum
FLNA is trading near the bottom of its 52-week range and below its 200-day simple moving average.
-
Price change
The price of FLNA shares has held flat since the market last closed. This is a 0.00% change.
-
Opened at $0.86.
The stock opened $0.01 lower than its previous close.
Key terms
About FLNA
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
-
Market cap: $42.01M
A market capitalization up to $300 million places FLNA in the micro-capitalization category.
Key terms
Smart score
Latest FLNA news
FLNA Financials
-
FLNA total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$90.97M (1Y), -$8.60M (Q2)
Net Income decreased 273.73% since last year and increased 16.73% since last quarter.
-
Earnings per share: -$1.88 (1Y), -$0.18 (Q2)
EPS decreased 28.84% since last year and increased 16.74% since last quarter.
Key terms
FLNA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
FLNA Competitors
-
How competitors are chosen
FLNA's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $42.01M
A market capitalization up to $300 million places FLNA in the micro-capitalization category.
